Metraipolis › archive › dc_77b7d183db6b

Lurasidone vs. Other Antipsychotics as Augmentation Strategies for Clozapine in Treatment-resistant Schizophrenia: An Observational Multicenter Prospective… — Europe PMC PMID:41088940

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41088940
DOI
10.2174/011570159x399781250910115949
License (as archived)
solo-consultazione
Archived
2026-11-07T04:42:47.435Z
SHA-256 of the archived text
2c816d10d38df90236999bf0deea91b911f99fbb7e5f42643326378df154467c
Stable URL of this page
https://metraipolis.com/documento/dc_77b7d183db6b

How to cite

Lurasidone vs. Other Antipsychotics as Augmentation Strategies for Clozapine in Treatment-resistant Schizophrenia: An Observational Multicenter Prospective… — Europe PMC PMID:41088940 — Europe PMC (en), https://europepmc.org/article/MED/41088940 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_77b7d183db6b (Metraipolis archive dc_77b7d183db6b, sha256 2c816d10d38df90236999bf0deea91b911f99fbb7e5f42643326378df154467c)
BibTeX
@misc{dc77b7d183db6b,
  title = {Lurasidone vs. Other Antipsychotics as Augmentation Strategies for Clozapine in Treatment-resistant Schizophrenia: An Observational Multicenter Prospective… — Europe PMC PMID:41088940},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41088940},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_77b7d183db6b; sha256 2c816d10d38df90236999bf0deea91b911f99fbb7e5f42643326378df154467c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41088940. Agents can read the archived copy with the MCP tool read_document.